Yvonne Greenstreet
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $24.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 13598,493 held (−0%) | $319.03 | $43K | -27.1% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 12998,364 held (−0%) | $320.01 | $41K | -27.3% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 27498,090 held (−0%) | $320.81 | $88K | -27.5% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 36897,722 held (−0%) | $321.82 | $118K | -27.7% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 44497,278 held (−0%) | $323.01 | $143K | -28.0% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 97396,305 held (−1%) | $323.84 | $315K | -28.1% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 34595,960 held (−0%) | $324.88 | $112K | -28.4% |
| Mar 6SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 26595,695 held (−0%) | $325.67 | $86K | -28.6% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 200105,227 held (−0%) | $323.62 | $65K | -28.1% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 382104,845 held (−0%) | $324.65 | $124K | -28.3% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1,098103,747 held (−1%) | $325.63 | $358K | -28.5% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1,669102,078 held (−2%) | $326.81 | $545K | -28.8% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1,399100,679 held (−1%) | $327.67 | $458K | -29.0% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 424100,255 held (−0%) | $328.71 | $139K | -29.2% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 72299,533 held (−1%) | $329.71 | $238K | -29.4% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 34699,187 held (−0%) | $330.85 | $114K | -29.7% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 39998,788 held (−0%) | $331.93 | $132K | -29.9% |
| Mar 4SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 16098,628 held (−0%) | $332.64 | $53K | -30.1% |
| Feb 17SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 6,95885,662 held (−8%) | $310.08 | $2.2M | -25.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 24787,741 held (−0%) | $353.95 | $87K | -34.3% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 26987,472 held (−0%) | $355.16 | $96K | -34.5% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 26387,209 held (−0%) | $356.09 | $94K | -34.7% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 60786,602 held (−1%) | $357.17 | $217K | -34.9% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 77885,824 held (−1%) | $358.18 | $279K | -35.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 53785,287 held (−1%) | $359.14 | $193K | -35.2% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 98084,307 held (−1%) | $360.22 | $353K | -35.4% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 62483,683 held (−1%) | $361.45 | $226K | -35.6% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 46483,219 held (−1%) | $362.38 | $168K | -35.8% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 30182,918 held (−0%) | $363.55 | $109K | -36.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1,25981,659 held (−2%) | $364.83 | $459K | -36.2% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1,39580,264 held (−2%) | $365.56 | $510K | -36.3% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 31679,948 held (−0%) | $366.41 | $116K | -36.5% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 26179,687 held (−0%) | $367.40 | $96K | -36.7% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 58479,103 held (−1%) | $368.62 | $215K | -36.9% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 25378,850 held (−0%) | $369.48 | $93K | -37.0% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 11878,732 held (−0%) | $370.87 | $44K | -37.3% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 2178,711 held (−0%) | $372.46 | $8K | -37.5% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 8878,623 held (−0%) | $374.44 | $33K | -37.9% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 11878,505 held (−0%) | $375.65 | $44K | -38.1% |
| Jan 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 9478,411 held (−0%) | $377.82 | $36K | -38.4% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 71180,348 held (−1%) | $448.07 | $319K | -48.1% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 2,13278,216 held (−3%) | $449.15 | $958K | -48.2% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 45377,763 held (−1%) | $450.17 | $204K | -48.3% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,25576,508 held (−2%) | $451.16 | $566K | -48.4% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,21075,298 held (−2%) | $452.43 | $547K | -48.6% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,06974,229 held (−1%) | $453.52 | $485K | -48.7% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,96072,269 held (−3%) | $454.84 | $891K | -48.8% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 3,40668,863 held (−5%) | $455.56 | $1.6M | -48.9% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 2,42066,443 held (−4%) | $456.64 | $1.1M | -49.0% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 60465,839 held (−1%) | $457.71 | $276K | -49.2% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 43065,409 held (−1%) | $458.42 | $197K | -49.2% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 65474,755 held (−1%) | $447.73 | $293K | -48.0% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,01373,742 held (−1%) | $448.76 | $455K | -48.2% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,47772,265 held (−2%) | $450.02 | $665K | -48.3% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 2,21870,047 held (−3%) | $450.69 | $1000K | -48.4% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,70268,345 held (−2%) | $451.94 | $769K | -48.5% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 1,59966,746 held (−2%) | $452.85 | $724K | -48.6% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 88165,865 held (−1%) | $453.99 | $400K | -48.7% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 19565,670 held (−0%) | $454.69 | $89K | -48.8% |
| Nov 14SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell Plan | 26165,409 held (−0%) | $456.03 | $119K | -49.0% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 35073,983 held (−0%) | $446.53 | $156K | -47.9% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 17173,812 held (−0%) | $447.92 | $77K | -48.1% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 54873,264 held (−1%) | $448.77 | $246K | -48.2% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 75872,506 held (−1%) | $449.79 | $341K | -48.3% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1,64270,864 held (−2%) | $450.81 | $740K | -48.4% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 1,01069,854 held (−1%) | $451.86 | $456K | -48.5% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 2,02967,825 held (−3%) | $452.69 | $919K | -48.6% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 99966,826 held (−1%) | $453.77 | $453K | -48.7% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 74166,085 held (−1%) | $454.84 | $337K | -48.8% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 22165,864 held (−0%) | $455.82 | $101K | -49.0% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 44665,418 held (−1%) | $457.43 | $204K | -49.1% |
| Oct 3SEC | ALNYAlnylam Pharmaceuticals, Inc. | Sell | 965,409 held (−0%) | $457.64 | $4K | -49.2% |
- Sell
CEO Yvonne Greenstreet sold $319K of ALNY at $448.07 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yvonne Greenstreet sold $958K of ALNY at $449.15 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yvonne Greenstreet sold $204K of ALNY at $450.17 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yvonne Greenstreet sold $566K of ALNY at $451.16 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yvonne Greenstreet sold $547K of ALNY at $452.43 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Yvonne Greenstreet sold $485K of ALNY at $453.52 — pre-scheduled 10b5-1 plan sale.